Short-Acting GHRH Analog
CJC-1295 (Without DAC)
VANTA-CJC-1295-WITHOUT-DAC
Performance
CJC-1295 (No DAC / Mod GRF 1-29), a short-acting GHRH analog studied for pulsatile GH release. ≥99% purity, third-party HPLC tested, batch COA included.
Subscribe & Save
Sun, Jul 19 - Thu, Jul 23
Free shipment protection
Overnight shipping available
We accept
Pay
VISA
DISC
AMEX
For laboratory and research use only. Not for human or veterinary consumption, and not for diagnostic or therapeutic use. These statements have not been evaluated by the FDA.
Product Details
CJC-1295 (without DAC), also known as Modified GRF (1-29), is a short-acting GHRH analog studied for stimulating the pituitary to release growth hormone in a natural, pulsatile pattern.
Without the Drug Affinity Complex its half-life is brief (roughly 30 minutes), which is the property of interest for researchers studying pulsatile rather than sustained GH signaling. It is commonly investigated alongside Ipamorelin.
Specs: ≥99% purity · lyophilized · batch-specific COA (HPLC + mass spec).
